Global Natural Killer (NK) Cell Therapeutics Market is growing with factors such as increase in usage of natural killer (NK) cells for the treatment of cancer and infectious diseases and rise in awareness about immunotherapies. Increasing investment in research and development also acts as a major factor for the growth of the market. Increase in patient population with chronic diseases and adoption of natural killer (NK) cell therapy in emerging markets has also given a boom to the global natural killer (NK) cell therapeutics market.
Advancement in natural killer (NK) cell therapies has propelled the demand of the market. However, lack of specificity and poor in-vivo survival of the cells and high cost associated with the therapies have decreased the demand of the market.
Global Natural Killer (NK) Cell Therapeutics Market Scenario
According to Data Bridge Market Research, the market for global natural killer (NK) cell therapeutics in North America has the highest market share followed by Europe and Asia-Pacific. Market leader is Merck KGaA, which accounts for an estimated market share of approximately 53.18% in the global natural killer (NK) cell therapeutics market. The company has gained outstanding sales by providing advanced PDL1 targeted NK cell therapy.
In March 2020, Merck KGaA along with Pfizer, Inc. obtained positive results from phase III trial of avelumab (a PDL1 targeted NK cell therapy) for treatment of advanced squamous cell carcinoma of the head and neck. This initiative helped the company to advance its NK cell therapy product portfolio for several types of disease treatment.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-n...
Natural Killer (NK) Cell Therapeutics Market Developments
In July 2020, Glycostem collaborated with the LUMICKS for enhancement of the NK- cell mediated immunotherapy. Through this collaboration the company added z-Movi to its product development procedure which helped it to accelerate the development of NK- cell based therapy.
In March 2018, Bristol-Myers Squibb Company signed a collaboration agreement with Nektar Therapeutics for the development of the CD122 biased agonist, a therapy that has the potential to expand the number of NK cells and enhance its cytotoxic activity against tumor cells. This agreement helped the company to accelerate the ongoing research and development activities of NK cell therapy.
Scope of the Natural Killer (NK) Cell Therapeutics Market
Global natural killer (NK) cell therapeutics market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Luxembourg , Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific , Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East and Africa.
All country based analysis of the global natural killer (NK) cell therapeutics market is further analysed based on maximum granularity into further segmentation. On the basis of therapeutics, the natural killer (NK) cell therapeutics market is segmented into NK cell therapies and NK cell directed antibodies. On the basis of approaches, the natural killer (NK) cell therapeutics market is segmented into antibody-dependent cell-mediated cytotoxicity (ADCC) and bispecific antibodies. On the basis of application, the natural killer (NK) cell therapeutics market is segmented into cancer, acute infectious diseases, immunoproliferative disorders, gastrointestinal diseases and others. On the basis of end user, the natural killer (NK) cell therapeutics market is segmented into hospitals, specialty clinics and research & academic institutes. On the basis of distribution channel, the natural killer (NK) cell therapeutics market is segmented into hospital pharmacies, direct tender and others.
Get Full Access of Report @
https://www.databridgemarketresearch.com/reports/global-natural-killer-n...
Key Pointers Covered in Natural Killer (NK) Cell Therapeutics Market Industry Trends and Forecast to 2027
Market Size
Top to Bottom Market Analysis
Recent Developments for Market Competitors
Recent Market Value for Different Countries
Market value and overview of natural killer (NK) cell therapeutics market
Company profiling of top eight players of natural killer (NK) cell therapeutics market
Key Market Competitors Covered in the Report
Kiadis Pharma
Cytovia Therapeutics
Nkarta, Inc.
Fate Therapeutics
EMERcell
Glycostem
Phio Pharmaceuticals
Innate Pharma, Inc.
INmuneBIO
Gamida Cell
Bellicum Phamaceuticals, Inc.
Acepodia Inc.
Affimed GmbH
multimmune GmbH
Bristol-Myers Squibb Company
Kleo Pharmaceuticals
iCell Gene Therapeutics
Takeda Pharmaceutical Company Limited
Regeneron Pharmaceuticals Inc.
NantKwest
Merck KGaA
Research Methodology: Natural Killer (NK) Cell Therapeutics Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market timeline analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC @
https://www.databridgemarketresearch.com/toc/?dbmr=global-natural-killer...
Global Natural Killer (NK) Cell Therapeutics Market Report Answers the Following Questions:
What are the key drivers of the Global Natural Killer (NK) Cell Therapeutics Market?
How is the Global Natural Killer (NK) Cell Therapeutics Market segmented by product type?
What is the current market size of the Global Natural Killer (NK) Cell Therapeutics Market?
What is the projected growth rate of the Global Natural Killer (NK) Cell Therapeutics Market in the next five years?
Who are the major players in the Global Natural Killer (NK) Cell Therapeutics Market and what is their market share?
What are the major distribution channels for the Global Natural Killer (NK) Cell Therapeutics Market?
What are the key trends in the Global Natural Killer (NK) Cell Therapeutics Market?
How does the Global Natural Killer (NK) Cell Therapeutics Market differ from regional markets?
How is the Global Natural Killer (NK) Cell Therapeutics Market affected by government regulations and policies?
What are the current and future opportunities in the Global Natural Killer (NK) Cell Therapeutics Market?
Top Trending Reports by DBMR:
Asia-Pacific Dental Aligners Market
https://www.databridgemarketresearch.com/reports/asia-pacific-dental-ali...
Middle East and Africa Cryptocurrency Mining Market
https://www.databridgemarketresearch.com/reports/middle-east-and-africa-...
North America Cryptocurrency Mining Market https://www.databridgemarketresearch.com/reports/north-america-cryptocur...
Middle East and Africa Biostimulants Market https://www.databridgemarketresearch.com/reports/middle-east-and-africa-...
Europe Hearing Aid Market https://www.databridgemarketresearch.com/reports/europe-hearing-aid-market
Europe Hearing Aids Market https://www.databridgemarketresearch.com/reports/europe-hearing-aids-market
Europe Vanilla (B2C) Market https://www.databridgemarketresearch.com/reports/europe-vanilla-b2c-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com